Terms: = Breast cancer AND DDX5, HLR1, 1655, ENSG00000108654, P17844, DKFZp686J01190, p68, G17P1, HUMP68
75 results:
1. AURKAIP1 actuates tumor progression through stabilizing ddx5 in triple negative breast cancer.
Tian W; Tang Y; Luo Y; Xie J; Zheng S; Zou Y; Huang X; Wu L; Zhang J; Sun Y; Tang H; Du W; Li X; Xie X
Cell Death Dis; 2023 Dec; 14(12):790. PubMed ID: 38040691
[TBL] [Abstract] [Full Text] [Related]
2. Wnt Signaling Pathway Collapse upon β-Catenin Destruction by a Novel Antimicrobial Peptide SKACP003: Unveiling the Molecular Mechanism and Genetic Activities Using breast cancer Cell Lines.
Selvarathinam K; Subramani P; Thekkumalai M; Vilwanathan R; Selvarajan R; Abia ALK
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770598
[TBL] [Abstract] [Full Text] [Related]
3. HNRNPU promotes the progression of triple-negative breast cancer via RNA transcription and alternative splicing mechanisms.
Han BY; Liu Z; Hu X; Ling H
Cell Death Dis; 2022 Nov; 13(11):940. PubMed ID: 36347834
[TBL] [Abstract] [Full Text] [Related]
4. Colorectal cancer concurrent gene signature based on coherent patterns between genomic and transcriptional alterations.
Shen MH; Huang CJ; Ho TF; Liu CY; Shih YY; Huang CS; Huang CC
BMC Cancer; 2022 May; 22(1):590. PubMed ID: 35637462
[TBL] [Abstract] [Full Text] [Related]
5. Knockdown of KRAB domain-associated protein 1 suppresses the proliferation, migration and invasion of thyroid cancer cells by regulating p68/DEAD box protein 5.
Lan H; Lin C; Yuan H
Bioengineered; 2022 May; 13(5):11945-11957. PubMed ID: 35549637
[TBL] [Abstract] [Full Text] [Related]
6. Identifying Patients Whose Symptoms Are Underrecognized During Treatment With breast Radiotherapy.
Jagsi R; Griffith KA; Vicini F; Boike T; Dominello M; Gustafson G; Hayman JA; Moran JM; Radawski JD; Walker E; Pierce L;
JAMA Oncol; 2022 Jun; 8(6):887-894. PubMed ID: 35446337
[TBL] [Abstract] [Full Text] [Related]
7. Circular RNA dehydrodolichyl diphosphate synthase facilitated triple-negative breast cancer progression via miR-362-3p/ddx5 axis.
Cui S; Zhang Y; Xing L; Li R; Piao Y; Liu H
Environ Toxicol; 2022 Jun; 37(6):1483-1494. PubMed ID: 35343646
[TBL] [Abstract] [Full Text] [Related]
8. Efficacy of MRI-Directed breast Ultrasound and Lesion Characteristics Affecting Visualization on breast Ultrasound.
Xiao L; Simmons C; Khanani S
Curr Probl Diagn Radiol; 2022; 51(5):717-721. PubMed ID: 35272882
[TBL] [Abstract] [Full Text] [Related]
9. PAK5 promotes RNA helicase ddx5 sumoylation and miRNA-10b processing in a kinase-dependent manner in breast cancer.
Li Y; Xing Y; Wang X; Hu B; Zhao X; Zhang H; Han F; Geng N; Wang F; Li Y; Li J; Jin F; Li F
Cell Rep; 2021 Dec; 37(12):110127. PubMed ID: 34936874
[TBL] [Abstract] [Full Text] [Related]
10. Upregulated expression of ddx5 predicts recurrence and poor prognosis in breast cancer.
Li K; Zhao G; Yuan H; Zhang J; Li Q; Gong D; Lin P
Pathol Res Pract; 2022 Jan; 229():153736. PubMed ID: 34923193
[TBL] [Abstract] [Full Text] [Related]
11. Raman imaging and statistical methods for analysis various type of human brain tumors and breast cancers.
Kopec M; Błaszczyk M; Radek M; Abramczyk H
Spectrochim Acta A Mol Biomol Spectrosc; 2021 Dec; 262():120091. PubMed ID: 34175760
[TBL] [Abstract] [Full Text] [Related]
12. WBP2 inhibits microRNA biogenesis via interaction with the microprocessor complex.
Tabatabaeian H; Lim SK; Chu T; Seah SH; Lim YP
Life Sci Alliance; 2021 Jul; 4(7):. PubMed ID: 34117091
[TBL] [Abstract] [Full Text] [Related]
13. Tumor suppressor DRD2 facilitates M1 macrophages and restricts NF-κB signaling to trigger pyroptosis in breast cancer.
Tan Y; Sun R; Liu L; Yang D; Xiang Q; Li L; Tang J; Qiu Z; Peng W; Wang Y; Ye L; Ren G; Xiang T
Theranostics; 2021; 11(11):5214-5231. PubMed ID: 33859743
[No Abstract] [Full Text] [Related]
14. LncRNA PRADX-mediated recruitment of PRC2/ddx5 complex suppresses UBXN1 expression and activates NF-κB activity, promoting tumorigenesis.
Li Y; Liu X; Cui X; Tan Y; Wang Q; Wang Y; Xu C; Fang C; Kang C
Theranostics; 2021; 11(9):4516-4530. PubMed ID: 33754075
[No Abstract] [Full Text] [Related]
15. BRCA2 promotes DNA-RNA hybrid resolution by ddx5 helicase at DNA breaks to facilitate their repair‡.
Sessa G; Gómez-González B; Silva S; Pérez-Calero C; Beaurepere R; Barroso S; Martineau S; Martin C; Ehlén Å; Martínez JS; Lombard B; Loew D; Vagner S; Aguilera A; Carreira A
EMBO J; 2021 Apr; 40(7):e106018. PubMed ID: 33634895
[TBL] [Abstract] [Full Text] [Related]
16. Phase transition of fibrillarin LC domain regulates localization and protein interaction of fibrillarin.
Kim E; Kwon I
Biochem J; 2021 Feb; 478(4):799-810. PubMed ID: 33522570
[TBL] [Abstract] [Full Text] [Related]
17. Transcriptomics and Prognosis Analysis to Identify Critical Biomarkers in Invasive breast Carcinoma.
Wu J; Liu XJ; Hu JN; Liao XH; Lin FF
Technol Cancer Res Treat; 2020; 19():1533033820957011. PubMed ID: 33176622
[TBL] [Abstract] [Full Text] [Related]
18. RX-5902, a novel β-catenin modulator, potentiates the efficacy of immune checkpoint inhibitors in preclinical models of triple-negative breast cancer.
Tentler JJ; Lang J; Capasso A; Kim DJ; Benaim E; Lee YB; Eisen A; Bagby SM; Hartman SJ; Yacob BW; Gittleman B; Pitts TM; Pelanda R; Eckhardt SG; Diamond JR
BMC Cancer; 2020 Nov; 20(1):1063. PubMed ID: 33148223
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic factors for breast cancer patients with T1-2 tumors and 1-3 positive lymph nodes and the role of postmastectomy radiotherapy in these patients.
Zhao JM; An Q; Sun CN; Li YB; Qin ZL; Guo H; Zeng X; Zhang YT; Wei LL; Han N; Sun SC; Zhang N
Breast Cancer; 2021 Mar; 28(2):298-306. PubMed ID: 32940902
[TBL] [Abstract] [Full Text] [Related]
20. Dopamine and cAMP-regulated phosphoprotein 32 kDa (DARPP-32) and survival in breast cancer: a retrospective analysis of protein and mRNA expression.
Kotecha S; Lebot MN; Sukkarn B; Ball G; Moseley PM; Chan SY; Green AR; Rakha E; Ellis IO; Martin SG; Storr SJ
Sci Rep; 2019 Nov; 9(1):16987. PubMed ID: 31740718
[TBL] [Abstract] [Full Text] [Related]
[Next]
